New Clinical Lab Services for Diagnosis of Invasive Fungal Infections
Immunetics, Inc., have launched its new MycoDx™ assay for invasive fungal infections, which will be offered through its clinical reference laboratory service in the US.
MycoDx™ is a multiplex molecular assay developed by Immunetics that can identify 21 fungal pathogens in a whole blood sample. Clinical samples can be tested directly with MycoDx, eliminating the prior culturing step required by many other assays. This capability reduces assay turnaround time, providing earlier results to clinicians to enable more effective treatment of life-threatening fungal infections.
The MycoDx Assay available through Immunetics’ clinical reference laboratory will provide:
- Results for a panel of 21 fungal targets including Candida, Aspergillus, Cryptococcus, Coccidioides, Fusarium and other species. Additional fungal targets are currently under development.
- Results directly from whole blood patient samples – no blood cultures required. Additional sample types are currently under development.
- Rapid assay turnaround time - 8 hours for all 21 targets (most current methods can take 48-72 hours or more)
For more information about clinical laboratory reference services and the MycoDx Invasive Fungal Infection Assay, visit the Immunetics website at www.immunetics.com or contact the company at 1-617-896-9100 or toll-free at 1-800-227-4765.
Tags: Yeasts & Moulds, Candida
Date Published: March 1, 2016
Source article link: Immunetics » company contact details
3M Microbial Luminescence System Kit Fast-Tracks UHT and ESL Beverage Testing
Low Cost, Automated Yeast Cell Counter - Counts in 15 Seconds
FDA Authorizes New Use of Test to ID Emerging Pathogen Candida auris
Protect Select Offers Superior Performance for Preservation of Microorganisms
Real-Time Incubator and Colony Counter Delivers Results from 8 Hrs